The Valley Desk

ArticleCancer treatment and research communicationsPublished

Real-world treatment patterns of patients with EGFR exon 20 insertion-mutated advanced NSCLC treated with amivantamab or mobocertinib after platinum-based chemotherapy: A multi-database cohort study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Cancer treatment and research communications
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Retrospective Studies; Longitudinal Studies
PubMed ID
40408939
Added to directory
Source checked

Report a correction or request removal